T1	intervention 50 87	granulocyte colony-stimulating factor
T2	eligibility 1248 1309	Adult patients receiving adjuvant or neoadjuvant chemotherapy
T3	No-of-participants 1698 1701	407
T4	intervention 1737 1747	filgrastim
T5	intervention 1762 1775	pegfilgrastim
T6	control 1783 1796	standard care
T7	outcome 2059 2061	NE
T8	outcome 2179 2182	RDI
T9	control-value 2204 2207	50%
T10	intervention-value 2253 2256	75%
T11	outcome 2320 2355	reduction in post-randomisation NEs
T12	control-value 2357 2362	65.7%
T13	intervention-value 2379 2384	18.2%
